TOXPLUS

TOXPLUS Monitoring, established January 2020, is a dedicated, client-focused company that provides nonclinical study oversight services including study monitoring, study management and vendor audits. We serve pharmaceutical and biotech companies in early to late stage drug development. Services include: • Study monitoring for non-GLP and GLP nonclinical studies (onsite or virtual) Our Study Monitors are located within driving distance to most US/Canadian CROs and are available to virtually monitor studies placed in Europe and Asia. They ensure that a study is conducted in compliance with an approved protocol, protocol amendments and regulatory guidelines. They provide oversite of procedures being performed, proper data collection and documentation of study results. • Data audit for non-GLP and GLP studies Our Data Auditors review all study notebooks to ensure data has been collected according to protocol and any deviations resolved. • Vendor audit/qualification (onsite or virtual) Our Auditors will ensure that a CRO has the capability to conduct a study and is qualified to do so from both a technical and quality compliance standpoint. • Study management of non-GLP and GLP nonclinical studies Our Study Managers will ensure your nonclinical program is executed according to its planned strategy. They will interact with Study Directors to address questions and keep the client up to date on all study events and outcomes. This is ideal for start-up to mid size companies without resources to support nonclinical study oversight. If you would like to learn more, please visit our website at www.toxplusmonitoring.com or contact us by email info@toxplusmonitoring.com or phone 1-800-604-6784.